Eli Lilly and Company (LLY) Release: Non-stimulant Strattera More Widely Available For Attention- Deficit/Hype
home > MSN news
Strattera is approved for the treatment of ADHD in children and adolescents in these countries. ... PRNewswire-FirstCall/ -- Eli Lilly and Company's Strattera(R) (atomoxetine HCl), the only approved non ...
- link to Eli Lilly and Company (LLY) Release: Non-stimulant Strattera More Widely Available For Attention- Deficit/Hype -
Last update: 06/01/2005